Calamos Advisors LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 35 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$2,523,000
+0.0%
2,423,0000.0%0.01%0.0%
Q4 2021$2,522,000
-4.6%
2,423,0000.0%0.01%
-25.0%
Q3 2021$2,644,000
-0.2%
2,423,0000.0%0.01%0.0%
Q2 2021$2,648,000
+0.9%
2,423,0000.0%0.01%
-14.3%
Q1 2021$2,625,000
-0.1%
2,423,0000.0%0.01%
-6.7%
Q4 2020$2,628,000
+4.6%
2,423,0000.0%0.02%
-6.2%
Q3 2020$2,513,000
-1.5%
2,423,0000.0%0.02%
-11.1%
Q2 2020$2,550,000
+1.3%
2,423,0000.0%0.02%
-10.0%
Q1 2020$2,517,000
-11.6%
2,423,0000.0%0.02%
+42.9%
Q4 2019$2,846,000
+17.5%
2,423,0000.0%0.01%
+7.7%
Q3 2019$2,423,000
-71.7%
2,423,000
-69.7%
0.01%
-72.9%
Q2 2019$8,566,000
-3.0%
8,000,0000.0%0.05%
-12.7%
Q1 2019$8,828,000
+16.9%
8,000,0000.0%0.06%
+10.0%
Q4 2018$7,553,000
-69.7%
8,000,000
-58.1%
0.05%
-63.5%
Q3 2018$24,956,000
-1.7%
19,115,000
+0.0%
0.14%
-11.6%
Q2 2018$25,382,000
+12.1%
19,109,000
+0.0%
0.16%
+5.4%
Q1 2018$22,652,000
+0.7%
19,103,000
-0.4%
0.15%
+27.8%
Q4 2017$22,484,000
-5.0%
19,174,000
-3.4%
0.12%
-37.2%
Q3 2017$23,659,000
-30.1%
19,852,000
-21.1%
0.18%
-26.8%
Q2 2017$33,870,000
-7.4%
25,165,000
-13.9%
0.25%
-13.2%
Q1 2017$36,586,000
+7.6%
29,230,000
-1.3%
0.29%
+6.7%
Q4 2016$33,996,000
-5.4%
29,610,000
-1.0%
0.27%
+5.1%
Q3 2016$35,930,000
+22.1%
29,924,000
+5.1%
0.26%
+24.8%
Q2 2016$29,422,00028,467,0000.21%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Mohican Financial Management, LLC 2,000,000$2,676,0004.66%
LINDEN ADVISORS LP 61,156,000$82,021,0003.46%
SSI INVESTMENT MANAGEMENT LLC 9,719,000$13,007,0001.15%
CSS LLC/IL 15,280,000$20,475,0000.99%
TENOR CAPITAL MANAGEMENT Co., L.P. 7,500,000$10,070,0000.92%
Castle Creek Arbitrage, LLC 4,000,000$5,361,0000.58%
DAFNA Capital Management LLC 573,000$767,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 30,968,000$41,494,0000.53%
Polar Asset Management Partners Inc. 15,000,000$20,086,0000.47%
OAKTREE CAPITAL MANAGEMENT LP 19,584,000$26,612,0000.44%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders